510(k) Report

510(k) · Cleared

Cleared

Quadrasphere 30 to 60

K113822510(k) SpecialCleared Mar 8, 201272-day reviewClass II21 CFR 882.5950

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biosphere Medical, Inc. · HCG Device, Neurovascular Embolization

Cleared on Mar 8, 2012 as substantially equivalent to K052742 (Biosphere Medical, Inc., 2006) after a 72-day review. Its family tree reaches back 5 generations to 2001. 1 later device descends from it.

Decided
Mar 8, 2012
Review
72 days
Class
Class II
Product code
HCG
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K010026 (2001). 12 ancestors in all, the oldest K871047 (1987). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2003: 1 other ancestor2002: 1 other ancestor2000: 1 other ancestor1994: 1 other ancestor1997: 1 other ancestor1996: 1 other ancestor1987: 1 other ancestor2015: 1 descendant clearedK010026 · Embogold Microsphere · Biosphere Medical, Inc. · 2001K023089 · Gelspheres Embolic Agent · Biocure, Inc. · 2002K033761 · Gelspheres / Beadblock Compressible Microspheres · Biocompatibles UK Limited · 2004K042231 · Gelspheres Microspheres and Bead Block Compressible Microspheres · Biocompatibles UK Limited · 2004K052742 · Hepasphere Microspheres · Biosphere Medical, Inc. · 20061990200020102020
  1. Root · 5 generations backK010026 Embogold MicrosphereBiosphere Medical, Inc. · 2001
  2. 4 generations backK023089 Gelspheres Embolic AgentBiocure, Inc. · 2002
  3. 3 generations backK033761 Gelspheres / Beadblock Compressible MicrospheresBiocompatibles UK Limited · 2004
  4. 2 generations backK042231 Gelspheres Microspheres and Bead Block Compressible MicrospheresBiocompatibles UK Limited · 2004
  5. 1 generation backK052742 Hepasphere MicrospheresBiosphere Medical, Inc. · 2006
  6. This deviceK113822 Quadrasphere 30 to 60Biosphere Medical, Inc. · 2012
  7. Descendant · cites it directly · 0 of its ownK151187 QuadraSphere MicrospheresBiosphere Medical, S.A. · 2015

Most influential descendants

Showing 1 of 1 · See all
  • K151187QuadraSphere MicrospheresBiosphere Medical, S.A. · 2015 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K010026Embogold MicrosphereBiosphere Medical, Inc.2001—
−4K023089Gelspheres Embolic AgentBiocure, Inc.2002—
−3K033761Gelspheres / Beadblock Compressible MicrospheresBiocompatibles UK Limited2004—
−2K042231Gelspheres Microspheres and Bead Block Compressible MicrospheresBiocompatibles UK Limited2004—
−1K052742Hepasphere MicrospheresBiosphere Medical, Inc.2006—
0 (this device)K113822Quadrasphere 30 to 60Biosphere Medical, Inc.2012—
+1K151187QuadraSphere MicrospheresBiosphere Medical, S.A.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
199410
199610
199710
200010
200210
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
FIG. 1 — Lineage of K113822, 2001–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HCG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HCG device

  1. #1 K252700 Optima Coil System (Optima Packing Coil System)score 20.6 · 26 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K052742Hepasphere Microspheres
Summary page 1
…QuadraSphere Microspheres Classification Name: Neurovascular embolization device Predicate Device Premarket Notification: K052742 Manufacturer: BioSphere Medical, S.A. Class 11 Classification…
Biosphere Medical, Inc.2006—

Also cleared against K052742: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K151187QuadraSphere MicrospheresBiosphere Medical, S.A.20150

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 3 companies; a new generation was cleared every 1.5 years on median.
  • None of the 12 ancestors has a recall.
  • Of its descendants, K151187 (Biosphere Medical, S.A., 2015) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K052742.

How does its category compare?

All HCG devices

HCG Device, Neurovascular Embolization: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · HCG

3in 2025

2007: 82008: 92009: 72010: 82011: 92012: 72013: 72014: 52015: 52016: 72017: 52018: 42019: 12020: 22021: 52022: 32023: 22024: 42025: 32026 (partial year): 4
2007high 9 (2008) · low 1 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HCG

107in 2025

2007: 50 days median2008: 71 days median2009: 48 days median2010: 72 days median2011: 78 days median2012: 30 days median2013: 67 days median2014: 66 days median2015: 60 days median2016: 37 days median2017: 97 days median2018: 173 days median2021: 103 days median2022: 114 days median2024: 49 days median2025: 107 days median2026 (partial year): 30 days median
2007high 173 (2018) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HCG

1in 2025

2007: 12008: 32010: 22011: 12013: 22014: 42022: 22024: 12025: 1, 1 Class I2026 (partial year): 1
2007high 4 (2014) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · HCG

537in 2025

2007: 3262008: 7302009: 8212010: 8512011: 8942012: 1,1462013: 1,1032014: 1,7292015: 1,5982016: 1,9912017: 2,4942018: 2,0582019: 1,7632020: 1,7542021: 2,2682022: 6632023: 5682024: 5522025: 537
2007high 2,494 (2017) · low 326 (2007)2025

MAUDE reports naming product code HCG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078501326
20089713730
20097480821
20108722851
20119781894
201273001,146
201376721,103
201456641,729
201556001,598
201673701,991
201759702,494
2018417302,058
20191—01,763
20202—01,754
2021510302,268
202231142663
20232—0568
20244491552
202531071 (1)537
20264301—

What is it indicated for?

QuadraSphere Microspheres are indicated for embolization of hypervascularized tumors and peripheral arteriovenous malformations.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K113822: Quadrasphere 30 to 60.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K113822

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026